Genes inducing agonistic effects by anti-c-Met antibody treatment and drug method using thereof

The present invention relates to a biomarker for searching a drug causing a side effect by an anti c-Met antibody treatment, and to a searching method using the same and, more specifically, to a biomarker for commonly increasing or decreasing the gene expression in the anti c-Met antibody, and to a method for searching the anti c-Met antibody having few side effects or searching a drug for reducing a side effect of the anti c-Met antibody. The application measure of the anti c-Met antibody is increased through the method, thereby enabling promotion of the development of a new anti-tumor agent.